https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-01-03 / PLoS ONE 2018;13(1):e0190638
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-01-03 / PLoS ONE 2018;13(1):e01906382018-01-03 00:00:002020-01-08 10:08:47EpCAM peptide-primed dendritic cell vaccination confers significant anti-tumor immunity in hepatocellular carcinoma cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
IOZK
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
IOZK2018-01-01 16:18:592019-02-10 11:33:47Buch Veröffentlichung von Prof. Dr. Schirrmacher: Quo vadis cancer therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-01-01 / J Cancer 2018;9(1):41-53
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-01-01 / J Cancer 2018;9(1):41-532018-01-01 00:00:002018-01-01 00:00:00Modulated electro-hyperthermia induced loco-regional and systemic tumor destruction in colorectal cancer allografts
